EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratracheal neomycin attenuates TBI-induced secondary brain injury via modulation of lung dysbiosis and inhibition of the NLRP3 inflammasome

Harry Jung, Dong Hyuk Youn, Hyun-Jung Kang, Sun-Wha Im, Seung-Ho Shin, Goeun Park, Sung Woo Han, Yong-Ho In, Jae Jun Lee, Jin Pyeong Jeon, Ji Young Hong

Translational Research · 2026-12 · 298 · 72-84

DOI: 10.1016/j.trsl.2026.09.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2026-12. Verfasst von Harry Jung und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of New Frontier Research Team, Hallym University College of Medicine, Chuncheon, Republic of Korea. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hallym University, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study is the first to investigate whether modulation of the lung microbiome after traumatic brain injury (TBI) can reduce secondary brain injury and promote neurological recovery. Moderate TBI was induced in adult male Sprague-Dawley rats, which were assigned to normal, TBI, or TBI with intratracheal neomycin treatment for three days. Bronchoalveolar lavage fluid (BAL) and lung tissues were collected on day 3, and brain neuropathology, neuroinflammation, and cognition were assessed on day 7. TBI induced marked neutrophil infiltration and alveolar interstitial edema, accompanied by elevated IL-6 and NOS2 expression in BAL fluid and increased Acinetobacter abundance (LEfSe, LDA score > 3, p < 0.05). Intratracheal neomycin treatment after TBI corrected lung dysbiosis, significantly reduced Acinetobacter abundance, and suppressed IL-6, RAGE, and NLRP3 inflammasome components (NLRP3, ASC, caspase-1, and IL-1β) in lung tissues. In the brain, neomycin improved novel object recognition, reduced IL-6, IL-1β, and NLRP3 inflammasome activation, attenuated GFAP and Iba-1 activation, decreased FJB- and TUNEL-positive cells, preserved blood-brain barrier integrity, and prevented synaptic injury. Serum IL-1β levels peaked on day 3 after TBI, but this elevation was substantially attenuated in neomycin-treated rats. Furthermore, restoration of viable Acinetobacter baumannii largely reversed the neuroprotective effects of neomycin, supporting a causal role for lung Acinetobacter in secondary brain injury after TBI. These findings suggest that early intratracheal neomycin instillation following TBI mitigates lung dysbiosis and NLRP3-mediated inflammation in both lung and brain, thereby reducing secondary brain injury via the lung-brain axis, highlighting translational therapeutic potential.

Schlagwörter

Stichwörter der Autor:innen

MicrobiotaNeomycinNeuroinflammationTraumatic brain injury

Autor:innen und Institutionen

  • Institute of New Frontier Research Team, Hallym University College of Medicine, Chuncheon, Republic of Korea.
  • Department of Biochemistry, Hallym University School of Medicine, Chuncheon-si, Gangwon-do, 24252, Republic of Korea.
  • Department of Neurosurgery, Hallym University College of Medicine, Chuncheon, Gangwon-do, Republic of Korea; Department of Medical Device Development, Seoul National University College of Medicine, Seoul 03080, Republic…
  • Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Gangwon-do, Republic of Korea. Electronic address: mdhong@hall…

Förderung

  • Hallym University
  • National Research Foundation

Zitieren

APA

Jung, H., Youn, D. H., Kang, H. J., Im, S. W., Shin, S. H., Park, G., Han, S. W., In, Y. H., Lee, J. J., Jeon, J. P., & Hong, J. Y. (2026). Intratracheal neomycin attenuates TBI-induced secondary brain injury via modulation of lung dysbiosis and inhibition of the NLRP3 inflammasome. Translational Research, 298, 72-84. https://doi.org/10.1016/j.trsl.2026.09.014

Vancouver

Jung H, Youn DH, Kang HJ, Im SW, Shin SH, Park G, et al. Intratracheal neomycin attenuates TBI-induced secondary brain injury via modulation of lung dysbiosis and inhibition of the NLRP3 inflammasome. Translational Research. 2026;298:72-84. doi:10.1016/j.trsl.2026.09.014

BibTeX
@article{Jung2026,
  author = {Jung, Harry and Youn, Dong Hyuk and Kang, Hyun-Jung and Im, Sun-Wha and Shin, Seung-Ho and Park, Goeun and Han, Sung Woo and In, Yong-Ho and Lee, Jae Jun and Jeon, Jin Pyeong and Hong, Ji Young},
  title = {Intratracheal neomycin attenuates TBI-induced secondary brain injury via modulation of lung dysbiosis and inhibition of the NLRP3 inflammasome},
  journal = {Translational Research},
  year = {2026},
  volume = {298},
  pages = {72--84},
  doi = {10.1016/j.trsl.2026.09.014}
}
Kostenlos starten →